A multicenter, multi-national, randomized, open-label, contraceptive efficacy study of Kyleena in healthy women

Trial Profile

A multicenter, multi-national, randomized, open-label, contraceptive efficacy study of Kyleena in healthy women

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Oct 2016

At a glance

  • Drugs Levonorgestrel (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Oct 2016 Results assessing efficacy and safety of Levonorgestrel according to age, parity and BMI were presented at the 72nd Annual Meeting of the American Society for Reproductive Medicine
    • 04 Oct 2016 According to a Bayer media release, Based on the data from this trial the company has concluded the European registration procedure to gain EU-wide marketing authorization low-dose levonorgestrel-releasing intrauterine system (LNG-IUS).
    • 04 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top